Literature DB >> 20685608

Cognitive domains affected by histamine H(1)-antagonism in humans: a literature review.

P Van Ruitenbeek1, A Vermeeren, W J Riedel.   

Abstract

The neurotransmitter histamine has been suggested to be involved in cognitive functioning. Generally, studies in animals have shown a decrease in performance after decreasing histamine neurotransmission and improved performance after increasing histamine neurotransmission. It is unclear, however, what role histamine plays in cognition in humans. Up until now, most data are derived from studies and reviews that aimed to assess the sedative potential of H(1)-antagonists and not the effects on cognition in particular. The objective of this paper is specifically to review which cognitive domains are affected by H(1)-antagonists. Taken together, 90 experimental studies on the performance effects of sedative H(1)-antagonists published between 1973 and 2009 were reviewed. Results showed that psychomotor skills and attention are most frequently impaired and memory the least. Tasks assessing memory that were affected usually required rapid responses. It was concluded that both the complexity of the task as well as the demand for information processing speed determines the sensitivity to the effects of central H(1)-antagonism. The importance of the sensitive cognitive domains to histaminergic dysfunction, as well as the relation between histamine related decrease in arousal and task performance deserve further research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685608     DOI: 10.1016/j.brainresrev.2010.04.008

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  10 in total

1.  Synthetic consciousness: the distributed adaptive control perspective.

Authors:  Paul F M J Verschure
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-19       Impact factor: 6.237

Review 2.  Sleep neurobiology from a clinical perspective.

Authors:  Rodrigo A España; Thomas E Scammell
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

3.  Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.

Authors:  William Cho; Paul Maruff; John Connell; Cindy Gargano; Nicole Calder; Scott Doran; Sabrina Fox-Bosetti; Aizza Hassan; John Renger; Gary Herman; Christopher Lines; Ajay Verma
Journal:  Psychopharmacology (Berl)       Date:  2011-06-07       Impact factor: 4.530

4.  Fully automated production of 11C-doxepin for PET imaging histamine H1 receptor.

Authors:  Hancheng Cai; Thomas J Mangner; Otto Muzik; Xin Lu; Pulak K Chakraborty; Diane C Chugani; Harry T Chugani
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

5.  Antihistamine induced blood oxygenation level dependent response changes related to visual processes during sensori-motor performance.

Authors:  Peter van Ruitenbeek; Annemiek Vermeeren; Mitul Ashok Mehta; Eva Isabell Drexler; Willem Jan Riedel
Journal:  Hum Brain Mapp       Date:  2013-10-18       Impact factor: 5.038

6.  Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span.

Authors:  Lucy Y Wang; Richard R Murphy; Brett Hanscom; Ge Li; Steven P Millard; Eric C Petrie; Douglas R Galasko; Carl Sikkema; Murray A Raskind; Charles W Wilkinson; Elaine R Peskind
Journal:  Neurobiol Aging       Date:  2013-04-30       Impact factor: 4.673

Review 7.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

8.  Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.

Authors:  Hiroyuki Kamei; Ami Isaji; Yukihiro Noda; Kazuhiro Ishikawa; Koji Senzaki; Kiyofumi Yamada; Kazumitsu Sugiura; Yasushi Tomita; Toshitaka Nabeshima
Journal:  Arch Dermatol Res       Date:  2011-12-01       Impact factor: 3.017

9.  On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.

Authors:  N N J J M van der Sluiszen; A Vermeeren; S Jongen; E L Theunissen; A C M van Oers; C J Van Leeuwen; A Maret; C Desforges; A Delarue; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2016-08-04       Impact factor: 4.530

Review 10.  The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Authors:  Zanna J Voysey; Roger A Barker; Alpar S Lazar
Journal:  Neurotherapeutics       Date:  2020-11-11       Impact factor: 7.620

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.